title: Extracolonic manifestations of familial adenomatous polyposis: desmoid tumours, and upper gastrointestinal adenomas and carcinomas.
abstract: It is well known that patients with familial adenomatous polyposis (FAP) are at considerable risk of developing extracolonic manifestations of the disease. Particularly, desmoid tumours of the abdominal cavity, and duodenal adenomas and carcinomas are the most serious ones. It is estimated that some 10% of the FAP patients will develop desmoids, whereas 50-90% of the FAP patients will get duodenal adenomas predominantly concentrated on or around the major papilla. Desmoid tumours and duodenal carcinomas are major causes of death in those patients in whom a prophylactic (procto)colectomy has been performed. Desmoids are histologically benign tumours, composed of mature fibroblasts. They usually grow slowly but they can become quite large and may compress or infiltrate surrounding viscera, which might cause significant morbidity as well as mortality. Successful treatment of these tumours is extremely difficult as surgical therapy often requires the removal of considerable lengths of small bowel. Moreover, surgical therapy may lead to uncontrollable bleeding and is seldom radical. Chemotherapy with cytoxic agents seems promising but so far the data are too few for firm conclusions to be drawn. The same holds true for drug regimens which interfere with the metabolic and hormonal metabolism of the tumour. Although various lines of evidence suggest that the adenoma-carcinoma sequence, which is generally accepted for colorectal adenomas, also applies for the duodenal adenomas in FAP patients, it is not clear whether we should screen these patients for upper gastrointestinal adenomas or not. As these polyps are usually small, sessile, multiple and difficult to remove, the benefit of endoscopic surveillance would be the early detection of cancer rather than eradication of the polyps. In addition, evidence that screening and early treatment leads to improvement of the prognosis is not available. Although the role of (procto)colectomy in the treatment of large-bowel polyps is well established in FAP patients, the treatment of their duodenal counterparts is still open for debate. The risk of the development of periampullary cancer is not high enough to warrant an aggressive prophylactic surgical approach, i.e. a Whipple's procedure, immediately after the discovery of duodenal adenomas. The considerable morbidity and mortality rates of this procedure must be weighted against a putative benefit of screening.
authors.affiliation: Dept. of Gastroenterology-Hepatology, Leiden University Medical Center, University Hospital Leiden, The Netherlands.
authors.forename: G
authors.initials: G
authors.lastname: Griffioen
authors.forename: P J
authors.initials: PJ
authors.lastname: Bus
authors.forename: H F
authors.initials: HF
authors.lastname: Vasen
authors.forename: H W
authors.initials: HW
authors.lastname: Verspaget
authors.forename: C B
authors.initials: CB
authors.lastname: Lamers
mesh_terms: D000236:Adenoma / Q000209:etiology* / Q000628:therapy; D011125:Adenomatous Polyposis Coli / Q000150:complications* / Q000473:pathology*; D002277:Carcinoma / Q000556:secondary* / Q000628:therapy; D004379:Duodenal Neoplasms / Q000556:secondary* / Q000628:therapy; D004724:Endoscopy; D018221:Fibromatosis, Abdominal / Q000209:etiology* / Q000628:therapy; D006801:Humans; D016737:Proctocolectomy, Restorative